Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exogenous surfactant therapy in newborns.

R J Rodriguez1, R J Martin

  • 1Division of Neonatology, Department of Pediatrics, Rainbow Babies and Children's Hospital, University Hospitals of Cleveland, Ohio 44106, USA.

Respiratory Care Clinics of North America
|November 24, 1999
PubMed
Summary

Surfactant replacement therapy significantly improves neonatal intensive care for premature infants with respiratory distress syndrome (RDS). Further research explores its role in other neonatal respiratory conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening for SIDS: A neonatal perspective.

Pediatrics·1999
Same author

Bronchopulmonary dysplasia--no simple solution.

The New England journal of medicine·1999
Same author

Resistance to levamisole resolved at the single-channel level.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·1999
Same author

A custom splint for zygomatic fractures.

Plastic and reconstructive surgery·1999
Same author

Assessment of the AirWatch lung function monitoring system. Asthma Clinical Research Network (ACRN).

The Journal of allergy and clinical immunology·1999
Same author

Is prescribing antibiotics by phone for respiratory infections acceptable? This expert says yes!

Postgraduate medicine·1999

Area of Science:

  • Neonatal Intensive Care
  • Pulmonology
  • Biochemistry

Background:

  • Respiratory distress syndrome (RDS) is a significant challenge in premature infants.
  • Surfactant replacement therapy has revolutionized RDS management.
  • The impact of surfactant therapy on chronic lung disease remains unclear.

Purpose of the Study:

  • To provide an overview of the surfactant system's physiology.
  • To discuss current applications of surfactant therapy in newborns.
  • To explore emerging uses and challenges in neonatal respiratory disorders.

Main Methods:

  • Literature review of surfactant physiology and therapy.
  • Analysis of clinical outcomes in neonatal respiratory conditions.
  • Discussion of surfactant inactivation in neonatal lung disease.

Main Results:

  • Surfactant therapy is a major advance in neonatal intensive care for RDS.
  • The effect on chronic lung disease incidence requires further investigation.
  • Surfactant inactivation plays a role in meconium aspiration syndrome and pneumonia.

Conclusions:

  • Surfactant therapy has transformed the care of premature infants with RDS.
  • New applications and challenges are emerging for surfactant therapy in neonates.
  • Understanding surfactant physiology is crucial for managing neonatal respiratory disorders.

Related Experiment Videos